Acyclovir 500 mg Injection

Acyclovir 500 mg Injection

Brand Name: ACYNIQ-500 Generic Name: Acyclovir for Injection USP

Strength: 500 mg per vial

Why Choose ACYNIQ-500?

ACYNIQ-500 contains high-purity Acyclovir, a synthetic purine nucleoside analogue. It is specifically designed for the treatment of severe, systemic viral infections where oral therapy is insufficient.

Pharmacodynamics

ACYNIQ-500 is a \"prodrug\" that only becomes active inside virus-infected cells. This ensures high efficacy while minimizing the impact on healthy, uninfected cells.

• Targeted Enzyme Activation: Uses viral thymidine kinase for activation.
• DNA Synthesis Inhibition: Terminates the viral DNA chain, preventing further replication.
• High Selectivity: Greater affinity for viral DNA polymerase than human DNA polymerase.

Primary Indications

• Herpes Simplex Encephalitis: Immediate intervention for life-threatening CNS infections.
• Neonatal Herpes Simplex: Essential care for newborns.
• Varicella-Zoster (Shingles): Severe infections in immunocompromised or high-risk patients.
• HSV-1 & HSV-2: Treatment of initial and recurrent mucosal and cutaneous infections.